货号:GS40343
Iratumumab (development code MDX-060) is an investigational, human anti-CD30 immunoglobulin G1 kappa (IgG1κ) monoclonal antibody developed for the treatment of CD30-expressing lymphomas. It functions as a targeted immunotherapeutic agent against the CD30 antigen. By binding with high affinity to CD30 on the surface of tumor cells, iratumumab exerts its antitumor effects through multiple potential mechanisms.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物